Ostrom QT, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014-2018. Neuro Oncol. 2021;23:iii1–iii105. https://doi.org/10.1093/neuonc/noab200
Article PubMed PubMed Central Google Scholar
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 2021;23:1231–51. https://doi.org/10.1093/neuonc/noab106
Article CAS PubMed PubMed Central Google Scholar
Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, et al. Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial. JAMA. 2015;314:2535–43. https://doi.org/10.1001/jama.2015.16669
Article CAS PubMed Google Scholar
Stupp R, Hegi ME, Gorlia T, Erridge SC, Perry J, Hong YK, et al. Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2014;15:1100–8. https://doi.org/10.1016/S1470-2045(14)70379-1
Article CAS PubMed Google Scholar
Wick W, Gorlia T, Bendszus M, Taphoorn M, Sahm F, Harting I, et al. Lomustine and bevacizumab in progressive glioblastoma. N. Engl J Med. 2017;377:1954–63. https://doi.org/10.1056/NEJMoa1707358
Article CAS PubMed Google Scholar
Reardon DA, Rich JN, Friedman HS, Bigner DD. Recent advances in the treatment of malignant astrocytoma. J Clin Oncol. 2006;24:1253–65. https://doi.org/10.1200/JCO.2005.04.5302
Article CAS PubMed Google Scholar
Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20:675–91. https://doi.org/10.1038/s41576-019-0158-7
Article CAS PubMed Google Scholar
Gao X, Xia X, Li F, Zhang M, Zhou H, Wu X, et al. Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR-STAT3 signalling. Nat Cell Biol. 2021;23:278–91. https://doi.org/10.1038/s41556-021-00639-4
Article CAS PubMed Google Scholar
Liu Y, Li Z, Zhang M, Zhou H, Wu X, Zhong J, et al. Rolling-translated EGFR variants sustain EGFR signaling and promote glioblastoma tumorigenicity. Neuro Oncol. 2021;23:743–56. https://doi.org/10.1093/neuonc/noaa279
Article CAS PubMed Google Scholar
Lou J, Hao Y, Lin K, Lyu Y, Chen M, Wang H, et al. Circular RNA CDR1as disrupts the p53/MDM2 complex to inhibit gliomagenesis. Mol Cancer. 2020;19:138 https://doi.org/10.1186/s12943-020-01253-y
Article CAS PubMed PubMed Central Google Scholar
Khan IN, Ullah N, Hussein D, Saini KS. Current and emerging biomarkers in tumors of the central nervous system: possible diagnostic, prognostic and therapeutic applications. Semin Cancer Biol. 2018;52:85–102. https://doi.org/10.1016/j.semcancer.2017.07.004
Article CAS PubMed Google Scholar
Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21:475–90. https://doi.org/10.1038/s41580-020-0243-y
Article CAS PubMed Google Scholar
Zhang Y, Qian J, Gu C, Yang Y. Alternative splicing and cancer: a systematic review. Signal Transduct Target Ther. 2021;6:78 https://doi.org/10.1038/s41392-021-00486-7
Article CAS PubMed PubMed Central Google Scholar
Li S, Han L. Circular RNAs as promising biomarkers in cancer: detection, function, and beyond. Genome Med. 2019;11:15 https://doi.org/10.1186/s13073-019-0629-7
Article PubMed PubMed Central Google Scholar
Shang Q, Yang Z, Jia R, Ge S. The novel roles of circRNAs in human cancer. Mol Cancer. 2019;18:6 https://doi.org/10.1186/s12943-018-0934-6
Article PubMed PubMed Central Google Scholar
Goodall GJ, Wickramasinghe VO. RNA in cancer. Nat Rev Cancer. 2021;21:22–36. https://doi.org/10.1038/s41568-020-00306-0
Article CAS PubMed Google Scholar
Wei Y, Lu C, Zhou P, Zhao L, Lyu X, Yin J, et al. EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS/MEK1/ERK1-2 signaling. Neuro Oncol. 2021;23:611–24. https://doi.org/10.1093/neuonc/noaa214
Article CAS PubMed Google Scholar
Zhang S, Liao K, Miao Z, Wang Q, Miao Y, Guo Z, et al. CircFOXO3 promotes glioblastoma progression by acting as a competing endogenous RNA for NFAT5. Neuro Oncol. 2019;21:1284–96. https://doi.org/10.1093/neuonc/noz128
Article CAS PubMed PubMed Central Google Scholar
Chen D, Chou FJ, Chen Y, Tian H, Wang Y, You B, et al. Targeting the radiation-induced TR4 nuclear receptor-mediated QKI/circZEB1/miR-141-3p/ZEB1 signaling increases prostate cancer radiosensitivity. Cancer Lett. 2020;495:100–11. https://doi.org/10.1016/j.canlet.2020.07.040
Article CAS PubMed Google Scholar
Shen S, Yang Y, Shen P, Ma J, Fang B, Wang Q, et al. circPDE4B prevents articular cartilage degeneration and promotes repair by acting as a scaffold for RIC8A and MID1. Ann Rheum Dis. 2021;80:1209–19. https://doi.org/10.1136/annrheumdis-2021-219969
Article CAS PubMed Google Scholar
Chen J, Luo H, Liu Y, Zhang W, Li H, Luo T, et al. Oxygen-self-produced nanoplatform for relieving hypoxia and breaking resistance to sonodynamic treatment of pancreatic cancer. ACS Nano. 2017;11:12849–62. https://doi.org/10.1021/acsnano.7b08225.
Article CAS PubMed Google Scholar
Man J, Yu X, Huang H, Zhou W, Xiang C, Huang H, et al. Hypoxic induction of vasorin regulates notch1 turnover to maintain glioma stem-like cells. Cell Stem Cell. 2018;22:104–.e6. https://doi.org/10.1016/j.stem.2017.10.005
Article CAS PubMed Google Scholar
Hsieh CH, Lin YJ, Wu CP, Lee HT, Shyu WC, Wang CC. Livin contributes to tumor hypoxia-induced resistance to cytotoxic therapies in glioblastoma multiforme. Clin Cancer Res. 2015;21:460–70. https://doi.org/10.1158/1078-0432.CCR-14-0618
Article CAS PubMed Google Scholar
Hambardzumyan D, Bergers G. Glioblastoma: defining tumor niches. Trends Cancer. 2015;1:252–65. https://doi.org/10.1016/j.trecan.2015.10.009
Article PubMed PubMed Central Google Scholar
Fornes O, Castro-Mondragon JA, Khan A, van der Lee R, Zhang X, Richmond PA, et al. JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2020;48:D87–D92. https://doi.org/10.1093/nar/gkz1001
Article CAS PubMed Google Scholar
Dudekula DB, Panda AC, Grammatikakis I, De S, Abdelmohsen K, Gorospe M. CircInteractome: a web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biol. 2016;13:34–42. https://doi.org/10.1080/15476286.2015.1128065
Qiu W, Guo X, Li B, Wang J, Qi Y, Chen Z, et al. Exosomal miR-1246 from glioma patient body fluids drives the differentiation and activation of myeloid-derived suppressor cells. Mol Ther. 2021;29:3449–64. https://doi.org/10.1016/j.ymthe.2021.06.023
Article CAS PubMed Google Scholar
Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17:272–83. https://doi.org/10.1038/nrg.2016.20
Article CAS PubMed Google Scholar
Gibbings D, Mostowy S, Jay F, Schwab Y, Cossart P, Voinnet O. Selective autophagy degrades DICER and AGO2 and regulates miRNA activity. Nat Cell Biol. 2012;14:1314–21. https://doi.org/10.1038/ncb2611
Article CAS PubMed PubMed Central Google Scholar
Sheu-Gruttadauria J, MacRae IJ. Phase transitions in the assembly and function of human miRISC. Cell. 2018;173:946–.e16. https://doi.org/10.1016/j.cell.2018.02.051
Article CAS PubMed PubMed Central Google Scholar
Sablok G, Zhao H, Sun X. Plant circular RNAs (circRNAs): transcriptional regulation beyond miRNAs in plants. Mol Plant. 2016;9:192–4. https://doi.org/10.1016/j.molp.2015.12.021
Article CAS PubMed Google Scholar
Huang S, Li X, Zheng H, Si X, Li B, Wei G, et al. Loss of super-enhancer-regulated circRNA Nfix induces cardiac regeneration after myocardial infarction in adult mice. Circulation. 2019;139:2857–76. https://doi.org/10.1161/CIRCULATIONAHA.118.038361
Article CAS PubMed PubMed Central Google Scholar
Wen G, Zhou T, Gu W. The potential of using blood circular RNA as liquid biopsy biomarker for human diseases. Protein Cell. 2021;12:911–46. https://doi.org/10.1007/s13238-020-00799-3
Article CAS PubMed Google Scholar
Niu Y, Lin Z, Wan A, Sun L, Yan S, Liang H, et al. Loss-of-function genetic screening identifies aldolase A as an essential driver for liver cancer cell growth under hypoxia. Hepatology. 2021;74:1461–79. https://doi.org/10.1002/hep.31846
留言 (0)